Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Not Available].

Martin Schlumberger

    Bulletin De L'Academie Nationale De Medecine
    |June 7, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Refractory thyroid cancers, including advanced differentiated, medullary, and anaplastic types, are rare but deadly. Oral tyrosine kinase inhibitors have significantly improved outcomes for these challenging thyroid cancer cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Post-Chornobyl thyroid papillary carcinomas display distinct past <sup>131</sup>I exposure and radiation-associated carcinogenesis molecular signatures at low and high thyroid doses.

    Scientific reports·2026
    Same author

    Rethinking prophylactic central neck dissection in clinically node-negative papillary thyroid cancer.

    The lancet. Diabetes & endocrinology·2026
    Same author

    Lesional dosimetry in <sup>131</sup>I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodine.

    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
    Same author

    Type 2 Deiodinase in Cancer-Associated Fibroblasts is Required to Sustain Growth of Poorly and Undifferentiated Thyroid Cancer.

    Thyroid : official journal of the American Thyroid Association·2025
    Same author

    The rise of thyroid cancer incidence in adolescents and young adults.

    The lancet. Diabetes & endocrinology·2025
    Same author

    Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases.

    Thyroid : official journal of the American Thyroid Association·2025
    Same journal

    [Advances and perspectives in vascularized composite allotransplantation preservation].

    Bulletin de l'Academie nationale de medecine·2025
    Same journal

    [COVID-19: Neurological manifestations and complications during the acute phase of the disease].

    Bulletin de l'Academie nationale de medecine·2024
    Same journal

    [Role of psychological factors in post-COVID-19 condition].

    Bulletin de l'Academie nationale de medecine·2023
    Same journal

    [From the origin of Sars-CoV-2 to dangerous virology/biology].

    Bulletin de l'Academie nationale de medecine·2023
    Same journal

    [Neurological forms of long COVID in adults: Critical approach].

    Bulletin de l'Academie nationale de medecine·2023
    Same journal

    [Post-COVID-19 syndrome].

    Bulletin de l'Academie nationale de medecine·2023
    See all related articles

    Area of Science:

    • Oncology
    • Endocrinology

    Background:

    • Refractory thyroid cancers are defined as those unresponsive to current treatments.
    • These include advanced differentiated thyroid cancer (not iodine-avid), medullary thyroid cancer, and anaplastic thyroid cancer.
    • Though rare, these cancers cause most thyroid cancer-related deaths.

    Purpose of the Study:

    • To summarize the characteristics and management of refractory thyroid cancers.
    • To highlight the impact of novel therapies on patient outcomes.

    Main Methods:

    • Review of epidemiological data for refractory thyroid cancer subtypes.
    • Analysis of treatment outcomes with tyrosine kinase inhibitors.

    Main Results:

    • Refractory thyroid cancers account for a significant proportion of thyroid cancer mortality.

    Related Experiment Videos

  • Oral tyrosine kinase inhibitors have demonstrated a transformative effect on the outcomes of these cancers.

    • Conclusions:

    • Refractory thyroid cancers require specialized multidisciplinary care.
    • Tyrosine kinase inhibitors represent a major advancement in managing these aggressive malignancies.